Physician profile
John Brebbia
NPI 1821017492
$827.78
in general payments reported to CMS, 2019-2025
9 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.67 · 2022: $152 · 2023: $89.51 · 2024: $122 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $255.42 | 2022-2025 | Wegovy, Saxenda |
| Medtronic, INC. | $133.71 | 2023-2024 | Signia |
| Innocoll Pharmaceuticals Limited | $132.82 | 2022 | |
| Teleflex LLC | $110.04 | 2025 | Titan Sgs Bailout Chuck |
| Lilly USA, LLC | $65.61 | 2024-2025 | Zepbound |
| Ambu INC. | $39.03 | 2023 | |
| Ethicon US, LLC | $38.26 | 2025 | Echelon; Endopath |
| Intuitive Surgical, INC. | $31.67 | 2021 | |
| W. L. Gore & Associates, INC. | $21.22 | 2025 | Gore Synecor Biomaterial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brebbia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.